<DOC>
	<DOCNO>NCT01070160</DOCNO>
	<brief_summary>The investigator aim conduct prospective un-blinded pilot study premenopausal woman diagnose Polycystic Ovarian Syndrome ( PCOS ) , define use criterion develop 1990 NICHD conference PCOS , undergo treatment ovulation induction Metformin . We propose improve insulin sensitivity use Metformin woman diagnose PCOS facilitatory influence uterine endometrium .</brief_summary>
	<brief_title>Endometrial Effects Metformin Action Women With Polycystic Ovarian Syndrome ( PCOS )</brief_title>
	<detailed_description>Endometrial assessment propose follow three month nine month treatment metformin ; expression specify marker respective time point compare baseline . Visit 1 : Screening - Signed informed consent - Comprehensive history intake - Physical exam : Vital sign , height , weight , waist circumference , waist : hip ratio - Urine pregnancy test - Subjects provide 10 day supply vaginal progesterone EMBx schedule day 6-8 progesterone use . Visit 2 : Baseline - Urine pregnancy test - Endometrium thickness measure via transvaginal ultrasound - EMBx : sample endometrial tissue send histopathology rule endometrial hyperplasia cancer - 20cc blood - Metformin prescription dispense per clinical care . - Women advise use barrier method contraception ( ie ; condom , contraceptive jelly foam , sponge , diaphragm , cervical cap ) duration study . Visits 3 5 ( Weeks 8-10 30-34 , respectively ) - Urine pregnancy test - A 10 day course vaginal progesterone allow schedule EMBx 's time point specify visit 1 Visits 4 6 ( Weeks 12 ± 1 week 36 ± 1 week respectively ) - The procedure specify baseline ( Visit 2 ) repeat .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Progesterone</mesh_term>
	<criteria>Premenopausal 1842 year age Diagnosed PCOS define chronic oligo amenorrhea ( 8 menstrual period annually ) ; biochemical hyperandrogenemia ( elevated total free testosterone ) /or clinical hyperandrogenism ( excessive facial hair &amp; /or acne ) ; exclusion common medical disorder ( normal thyroid function test serum prolactin exclusion 21hydroxylase deficiency fast 17hydroxyprogesterone &lt; 200 ng/dl ) . Acceptable health basis interview , medical history , physical examination , laboratory test ( CBC , SMA20 , urinalysis ) perform within past 6 month Able provide sign informed consent Able comply study requirement Willing delay start clinically prescribed metformin treatment Known diabetic clinically significant know pulmonary , cardiac , renal , hepatic , neurologic , psychiatric , infectious , neoplastic malignant disease ( nonmelanoma skin cancer ) Current use hormonal contraceptive Seeking pregnancy ; use fertility drug within 6 month study Current recent ( within 3 month ) use metformin Ingestion investigational drug within two month prior study onset Evidence endometrial hyperplasia cancer upon baseline EMBx</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>42 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Polycystic Ovarian Syndrome ( PCOS )</keyword>
	<keyword>Metformin</keyword>
	<keyword>Endometrin</keyword>
</DOC>